News
Doctors might be able to predict a newborn's long-term health outlook, by analyzing their umbilical cord blood, a new study ...
INmune Bio to receive US patent for next-generation mesenchymal stromal cell product, CORDStrom: Boca Raton, Florida Saturday, April 19, 2025, 17:00 Hrs [IST] INmune Bio Inc., a c ...
The scientific team at JuveXO®, one of the most advanced exosome-based solutions available today, is thrilled to announce the ...
Cord blood transplants can help save the lives of patients with leukemia as well as other blood cancers and genetic diseases. Found in the placenta and the umbilical cords of newborns, cord blood stem ...
Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...
Mesenchymal stem cells (MSCs) are adult stem cells in several organs, including the umbilical cord, bone marrow ... and identification kits for MSC culture to assist in research and development.
Consider the poignant story of your baby's umbilical cord. For nine months it faithfully served as your baby's lifeline. It provided him with oxygen, with nutrients, with life itself. Now ...
Unlike traditional MSC products, CORDStromâ„¢ comprises pooled, culture-expanded human umbilical cord-derived MSCs (hucMSCs) designed for infusion or injection, potentially offering scalable ...
INmune Bio (INMB) announced a major intellectual property milestone with respect to its next-generation mesenchymal stromal cell, MSC, product, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results